HEBA EL-JAFARAWI: Open Payments
NPI 1649885138 · VERNON ROCKVILLE, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$289 in 12 payments from 8 companies in 2025. Trend: 2023 $228 · 2024 $1,618 · 2025 $289
Food & beverage: $289
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $85 |
| AstraZeneca Pharmaceuticals LP | 2 | $45 |
| Mallinckrodt Hospital Products Inc. | 1 | $40 |
| ALK-Abello, Inc | 1 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| PFIZER INC. | 1 | $25 |
| Insmed, Inc. | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
Products named: NUCALA, ACTHAR, Odactra, OFEV, TEZSPIRE, PAXLOVID, TRELEGY ELLIPTA, Arikayce.
Industry payments across CT — which companies pay providers there.
